Yoseph Shaaltiel

2010

In 2010, Yoseph Shaaltiel earned a total compensation of $538.9K as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 13% decrease compared to previous year.

Compensation breakdown

Bonus$100,000
Option Awards$70,286
Salary$292,095
Other$76,491
Total$538,872

Shaaltiel received $292.1K in salary, accounting for 54% of the total pay in 2010.

Shaaltiel also received $100K in bonus, $70.3K in option awards and $76.5K in other compensation.

Rankings

In 2010, Yoseph Shaaltiel's compensation ranked 7,419th out of 10,439 executives tracked by ExecPay. In other words, Shaaltiel earned more than 28.9% of executives.

ClassificationRankingPercentile
All
7,419
out of 10,439
29th
Division
Manufacturing
2,731
out of 3,838
29th
Major group
Chemicals And Allied Products
651
out of 921
29th
Industry group
Drugs
442
out of 680
35th
Industry
Biological Products, Except Diagnostic Substances
81
out of 142
43rd
Source: SEC filing on September 19, 2013.

Shaaltiel's colleagues

We found five more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2010.

2010

David Aviezer

Protalix BioTherapeutics

Chief Executive Officer

2010

Sandra Lauterbach

Protalix BioTherapeutics

Vice President, Sales and Commercial Affairs

2010

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

2010

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2010

Tzvi Palash

Protalix BioTherapeutics

Chief Operating Officer

News

You may also like